Abstract:Purpose Itraconazole (ITZ) is a synthetic triazole antifungal agent, which is widely used for treatment and prevention of fungal infections. The purpose of this study is to develop ITZ-loaded poly(lactic-co-glycolic acid) (PLGA) nanospheres (PLGA-ITZ-NS) as a new sustained-release formulation for intravenous ITZ administration. Materials and methods PLGA-ITZ-NS were prepared by a nanoprecipitation method and optimized by modifying the surfactant poloxamer 188 concentration and PLGA:ITZ ratio. Their physicochemical properties, including size, zeta potential, external morphology and encapsulation efficiency, were characterized by dynamic light scattering (DLS), scanning electron microscopy (SEM) and high performance liquid chromatography (HPLC). The effect of the different selected lyoprotectants with various concentrations on NS particles size and surface charge were also assessed. Rapid and sensitive HPLC and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were developed to determine ITZ concentrations in formulation and in rat plasma, respectively. Pharmacokinetics of the optimum PLGA-ITZ-NS formulation was compared with the former commercial Sporanox® injection formulation using rats as the animal model. Noncompartmental pharmacokinetic parameters were obtained by WinNonlin® software. Results Optimal PLGA-ITZ-NS had a mean particle size of about 200 nm with a high homogeneity (polydispersity index ≈0.2), favorable zeta potential (approximately −20 to −30 mV) and encapsulation efficiency (72%). In addition, 2% w/v sucrose was selected as a lyoprotectant for NS freeze-drying. The newly developed LC-MS/MS assay was validated and found to be accurate and precise. The in vivo study showed that the NS formulation has a similar systemic bioavailability to Sporanox® while providing a sustained plasma level (> 100 ng/mL) for up to 24 hours after intravenous administration. Conclusion Our newly developed PLGA-ITZ-NS has shown great sustained release and comparable bioavailability with Sporanox®, therefore having the potential to be an alternative injectable formulation of ITZ.

Formulation and Characterization of Immediate-Release Itraconazole-Loaded Pellets Prepared by Fluidized Bed Spray Coating

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Preparation of Itraconazole Amorphous Solid Dispersion and Preliminary Evaluation in Vitro

Preparation and in Vitro Release Study of Sustained-release Coated Pellets Containing Clarithromycin

Preparation of Itraconazole Solid Dispersion with PVP and Dissolution Experiment in Vitro

Preparation and physico-chemical properties of itraconazole polymeric micelles using mPEG-PLA as a drug carrier

Preparation and In-Vitro Release of Metformin Hydrochloride Sustained-Release Pellets

Preparation and Quality Evaluation of Ibuprofen Sustained Release Pellet Capsules Based on Solid Dispersion Technology

Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole

Preparation and Characterization of a Novel Aqueous Dispersion for Enteric Coating of Pantoprazole Sodium Pellets

Development of PLGA-based itraconazole injectable nanospheres for sustained release

Application of Ethyl Cellulose, Microcrystalline Cellulose and Octadecanol for Wax Based Floating Solid Dispersion Pellets

Improve Solubility and Develop Personalized Itraconazole Dosages via Forming Amorphous Solid Dispersions with Hydrophilic Polymers Utilizing HME and 3D Printing Technologies

Preparation and in Vitro Evaluation of Zaleplon Pulsatile Release Pellets

Formulation and Evaluation of Lipid-based Nanoformulation of Itraconazole

Formulation and Evaluation of Delayed Release Pellets of Ivabradine Hydrochloride

Preparation of Sustained-Release and Enteric Coated Pellets of Pantoprazole

Preparation of Double Pulse Control Release Pellets of Zolpidem Tartrate

[Study on the Preparation of Sustained-Release Pellets Containing Active Components from Gastrodia Elata by Fluid-Bed Coating].

Preparation and Characterization of Itraconazole Albumin Nanosuspensions

Orthogonal Experiments Optimizes the Formulations and Preparation Conditions of Itraconazole Solid Lipid Nanoparticles